Detalhe da pesquisa
1.
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
BMC Cancer
; 24(1): 735, 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38879498
2.
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
Int J Mol Sci
; 25(5)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473737
3.
Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
Cancer Treat Rev
; 126: 102723, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555857
4.
Management of PALB2-associated breast cancer: A literature review and case report.
Clin Case Rep
; 11(8): e7747, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621724